Abstract
Ninety infants and children were prospectively randomized to receive cefepime (n = 43) or cefotaxime (n = 47) for therapy of bacterial meningitis. The two treatment groups were comparable in terms of age, duration of illness before enrollment, history of seizures, clinical status on admission, and etiology. Six (7%) patients died--two treated with cefepime and four treated with cefotaxime. Clinical response, cerebrospinal fluid sterilization, development of complications, antibiotic toxicity, and hospital stay were similar for the two treatment regimens. Concentrations of cefepime in cerebrospinal fluid varied from 55 to 95 times greater than the maximal MIC required by the causative pathogens. Audiologic and/or neurologic sequelae were found in 16% of the cefepime-treated patients and 15% of the cefotaxime-treated patients examined 2 to 6 months after discharge. We conclude that cefepime is safe and therapeutically equivalent to cefotaxime for management of bacterial meningitis in infants and children.
Full Text
The Full Text of this article is available as a PDF (176.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Baraff L. J., Lee S. I., Schriger D. L. Outcomes of bacterial meningitis in children: a meta-analysis. Pediatr Infect Dis J. 1993 May;12(5):389–394. doi: 10.1097/00006454-199305000-00008. [DOI] [PubMed] [Google Scholar]
- Feigin R. D., McCracken G. H., Jr, Klein J. O. Diagnosis and management of meningitis. Pediatr Infect Dis J. 1992 Sep;11(9):785–814. doi: 10.1097/00006454-199209000-00039. [DOI] [PubMed] [Google Scholar]
- Kessler R. E., Bies M., Buck R. E., Chisholm D. R., Pursiano T. A., Tsai Y. H., Misiek M., Price K. E., Leitner F. Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics. Antimicrob Agents Chemother. 1985 Feb;27(2):207–216. doi: 10.1128/aac.27.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kim K. S., Bayer A. S. Efficacy of BMY-28142 in experimental bacteremia and meningitis caused by Escherichia coli and group B streptococci. Antimicrob Agents Chemother. 1985 Jul;28(1):51–54. doi: 10.1128/aac.28.1.51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Klass P. E., Klein J. O. Therapy of bacterial sepsis, meningitis and otitis media in infants and children: 1992 poll of directors of programs in pediatric infectious diseases. Pediatr Infect Dis J. 1992 Sep;11(9):702–705. doi: 10.1097/00006454-199209000-00005. [DOI] [PubMed] [Google Scholar]
- Masuyoshi S., Hiraoka M., Inoue M., Tomatsu K., Hirano M., Mitsuhashi S. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime. Drugs Exp Clin Res. 1989;15(1):1–10. [PubMed] [Google Scholar]
- Odio C. M., Faingezicht I., Paris M., Nassar M., Baltodano A., Rogers J., Sáez-Llorens X., Olsen K. D., McCracken G. H., Jr The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med. 1991 May 30;324(22):1525–1531. doi: 10.1056/NEJM199105303242201. [DOI] [PubMed] [Google Scholar]
- Sanders C. C. Cefepime: the next generation? Clin Infect Dis. 1993 Sep;17(3):369–379. [PubMed] [Google Scholar]
- Sáez-Llorens X., Ramilo O., Mustafa M. M., Mertsola J., McCracken G. H., Jr Molecular pathophysiology of bacterial meningitis: current concepts and therapeutic implications. J Pediatr. 1990 May;116(5):671–684. doi: 10.1016/s0022-3476(05)82647-2. [DOI] [PubMed] [Google Scholar]
- Tomatsu K., Ando S., Masuyoshi S., Hirano M., Miyaki T., Kawaguchi H. Antibacterial activity of BMY-28142, a novel broad-spectrum cephalosporin. J Antibiot (Tokyo) 1986 Nov;39(11):1584–1591. doi: 10.7164/antibiotics.39.1584. [DOI] [PubMed] [Google Scholar]
- Tsai Y. H., Bies M., Leitner F., Kessler R. E. Therapeutic studies of cefepime (BMY 28142) in murine meningitis and pharmacokinetics in neonatal rats. Antimicrob Agents Chemother. 1990 May;34(5):733–738. doi: 10.1128/aac.34.5.733. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Täuber M. G., Hackbarth C. J., Scott K. G., Rusnak M. G., Sande M. A. New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits. Antimicrob Agents Chemother. 1985 Mar;27(3):340–342. doi: 10.1128/aac.27.3.340. [DOI] [PMC free article] [PubMed] [Google Scholar]